Form D · Biotechnology
Oncolix, Inc.
Houston, TX · CIK 0001574061
Offering snapshot reported Feb 6, 2017 · SEC filing
- Reported sold
- $250K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jan 20, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2017 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Oct 25, 2016 | Amendment | $150,000 | $0vs Oct 4, 2016 | 2 | SEC filing |
| Oct 4, 2016 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Jan 22, 2015 | Initial | $4,508,704 | No comparison | 5 | SEC filing |
| May 14, 2013 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| May 14, 2013 | Initial | $2,400,000 | No comparison | 1 | SEC filing |
| May 14, 2013 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $400K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-280080
The offering is for up to $5,000,000 in total.
Assuming the maximum offering
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NewBridge Securities Corporation | 104065 | NewBridge Securities Corporation · CRD 104065 |
Source: Form D, filed Feb 6, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J Donald Payne | Executive |
| J Donald Payne | Executive |
| Joseph Podolski | Director |
| Michael T Redman | Director, Executive |
| Jerry Youkey | Director |
| Dale Zajicek | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14405 Walters Road, Suite 780
Houston, TX, 77014
Houston, TX, 77014